Figure S2 from HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine
Preprint 2025 en
Authors
ML
Morgane Lecointre
JG
Jérémy Guillot
RM
Rachel Marcone
Abstract
1 min read
<p>Further characterization of the K14HPV16/H2b GEMM and syngeneic tumor models leading to identification of candidate SIS-inducing ligands.</p>
Discussion(0)
No comments yet. Be the first to comment.